GTBI
Green Thumb Industries Inc.Company Intelligence Hub
Filing history, signal momentum, and bull/bear evolution
Chronological Filing Evolution (Click to filter / toggle)
Thesis (Bull Case Evolution)
Green Thumb Industries is transitioning from a pure growth play into a cash-generating compounder. The company reported a pivotal first quarter for 2026, with net income surging 85% to $15.4 million.…
Antithesis (Bear Case / Structural Risks)
Despite the headline growth in net income, a closer look at the fundamentals reveals a business facing significant margin erosion. Gross margins declined from 51% to 48% as cost of goods sold surged 15%, far outpacing the 7% revenue growth.…
Read the full bull/bear analysis
You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every GTBI filing.
Synthesis (Verdict & Resolution)
The Q1 2026 filing presents a company at a crossroads between operational maturity and structural risk. On one hand, the explosive growth in net income and the move toward fixed licensing costs suggest a business that has found its footing and is ready to scale efficiently. On the other, the divergence between rising costs and modest revenue growth indicates that price compression is a real and present danger in the competitive cannabis landscape. Ultimately, the investment thesis hinges on two primary factors: the execution of the retail expansion and the timing of federal regulatory shifts. If the DOJ's rescheduling of marijuana to Schedule III materializes, the resulting tax relief would be a generational catalyst for the company's bottom line. However, until that occurs, investors must weigh the benefit of aggressive buybacks against the risk of a debt-to-EBITDA ratio that leaves the company with very little margin for operational volatility.
Core Takeaway
The company is achieving high net income growth and returning capital, but core gross margins are slipping due to price compression and new licensing fees.
Investor Lens
The trade-off between aggressive shareholder returns and the need for a liquidity buffer to manage debt covenants.
Watch Next
The DOJ's administrative hearing on marijuana rescheduling starting June 29, 2026.
Signal Momentum Chart
Quarterly net bull/bear signal ratio. Click nodes to select a quarter.
Signal Timeline
Filing History
The Q1 2026 filing presents a company at a crossroads between operational maturity and structural risk. On one hand, the explosive growth in net income and the move toward fixed licensing costs suggest a business that has found its footing and is ready to scale efficiently. On the other, the divergence between rising costs and modest revenue growth indicates that price compression is a real and present danger in the competitive cannabis landscape. Ultimately, the investment thesis hinges on two primary factors: the execution of the retail expansion and the timing of federal regulatory shifts. If the DOJ's rescheduling of marijuana to Schedule III materializes, the resulting tax relief would be a generational catalyst for the company's bottom line. However, until that occurs, investors must weigh the benefit of aggressive buybacks against the risk of a debt-to-EBITDA ratio that leaves the company with very little margin for operational volatility.
Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.